MPH Health Care AG (93M1) AI Stock Analysis

• Market Cap: €76.85M
• Dividend Yield: 6.69%
• Average Volume (3M): 1.89K
• Price to Earnings (P/E): 2.4
• Beta (1Y): 0.05
• Revenue Growth: -15.43%
• EPS Growth: 8.45%
• Country: DE
• Employees: 2
• Sector: Healthcare
• Sector Strength: 47
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): N/A
• Shares Outstanding: 4,281,384
• 10 Day Avg. Volume: 1,483
• 30 Day Avg. Volume: 1,894
• PEG Ratio: N/A
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €20.00
• Price Target Upside: 11.42% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0

• Rating: 73 Outperform
• Price Target: €20.00 ▲(11.42% Upside)

The stock's strong financial performance and attractive valuation are the primary strengths, offset by technical indicators suggesting bearish momentum. Revenue fluctuations and cash flow volatility are concerns that need addressing.

MPH Health Care AG Business Overview & Revenue Model

Company Description

MPH Health Care AG, an investment company, engages in the healthcare business in Germany. It produces and sells medicinal products for the therapies of cancer, HIV, and other chronic diseases. The company also offers medical aesthetic treatments; and develops and sells pharmaceutical and medical products; and provides related services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. In addition, it is involved in the provision of cytostatic solutions; and real estate activities. The company was formerly known as MPH Mittelständische Pharma Holding AG and changed its name to MPH Health Care AG in 2017. The company was founded in 2008 and is based in Berlin, Germany. MPH Health Care AG is a subsidiary of Magnum AG.

How the Company Makes Money

MPH Health Care AG makes money through its strategic investments and holdings in various healthcare-related companies. The company earns revenue from dividends, interest, and capital gains on its investments. Its key revenue streams include income from investments in pharmaceutical companies, medical technology firms, and healthcare service providers. The company leverages its industry expertise to identify promising investment opportunities and actively manages its portfolio to maximize returns. Significant partnerships and market trends in the healthcare sector also contribute to MPH Health Care AG's earnings by driving the growth and profitability of its portfolio companies.

MPH Health Care AG Financial Statement Overview

Summary

MPH Health Care AG demonstrates strong profitability and financial stability with a robust balance sheet and effective cost management. However, revenue fluctuations and cash flow volatility are areas of concern.

Income Statement

MPH Health Care AG has shown improvement in key profitability metrics over recent years. The gross profit margin is strong, and there is a consistent net profit margin indicating profitability. However, revenue has fluctuated significantly, with a notable decline in 2024. Despite these fluctuations, EBIT and EBITDA margins remain healthy, reflecting effective cost management.

Balance Sheet

The company's balance sheet is robust, with a high equity ratio and a low debt-to-equity ratio, indicating financial stability. The return on equity is impressive, reflecting efficient use of shareholder funds. The company has managed its liabilities well, maintaining a solid stockholders' equity position, which suggests strong financial health.

Cash Flow

Cash flow analysis reveals some concerns, particularly with operating cash flow being negative in recent years, although it has turned positive in the latest period. The free cash flow shows significant volatility, but recent improvements in free cash flow growth are positive. The ratios indicate a need for better alignment of cash flow generation with net income.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	6.11M	7.24M	6.85M	4.36M	-9.02M
Gross Profit	6.11M	125.94M	6.80M	4.01M	-9.45M
EBITDA	33.32M	30.36M	29.68M	-9.05M	-71.00M
Net Income	32.04M	29.54M	29.11M	-8.96M	-70.38M
Balance Sheet
Total Assets	291.06M	266.35M	236.99M	198.00M	210.71M
Cash, Cash Equivalents and Short-Term Investments	1.20M	5.10M	3.82M	4.44M	4.23M
Total Debt	10.56M	13.05M	12.99M	4.05M	7.62M
Total Liabilities	13.19M	15.39M	15.57M	5.69M	9.45M
Stockholders Equity	277.87M	250.97M	221.42M	192.31M	201.26M
Cash Flow
Free Cash Flow	1.83M	-2.02M	-170.41K	-1.28M	-3.36M
Operating Cash Flow	1.83M	-2.02M	-164.79K	-1.28M	-3.36M
Investing Cash Flow	3.40M	5.40M	-8.96M	6.37M	12.83M
Financing Cash Flow	-7.70M	7.74M	-3.02M	-3.61M	-10.90M

MPH Health Care AG Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 17.95
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:93M1, the sentiment is Negative. The current price of 17.95 is above the 20-day moving average (MA) of 17.92, above the 50-day MA of 17.92, and below the 200-day MA of 20.91, indicating a bearish trend. The MACD of -0.12 indicates Positive momentum. The RSI at 44.54 is Neutral, neither overbought nor oversold. The STOCH value of 40.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for DE:93M1.

MPH Health Care AG Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
PSG	75 Outperform	€376.80M	18.14	48.46%	0.16%	13.80%	10.94%
93M1	73 Outperform	€76.85M	2.35	12.12%	6.69%	-15.43%	8.45%
AJ91	72 Outperform	€59.40M	11.24	13.65%	6.04%	0.69%	132.12%
LIK	62 Neutral	€102.00M	32.03	18.60%	―	0.76%	-8.38%
APPH	58 Neutral	€92.23M	138.04	2.09%	―	27.42%	―
Sector *	51 Neutral	$7.83B	-0.18	-40.10%	2.29%	21.46%	-2.03%
HAEK	―	€53.67M	―		―	―	―